Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (221-230 of 491) with videos related to

Pageof 50
Sort By:
United European Gastroenterology Journal|June 19, 2019
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascitesBenedikt Simbrunner, Annika Röthenbacher, Helmuth Haslacher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2022
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertensionDavid Bauer, Karin Kozbial, Philipp Schwabl, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 28, 2022
Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled ElastographyDavid Jm Bauer, Vladimir Matic, Ruxandra Mare, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2013
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingThomas Reiberger, Berit Anna Payer, Philipp Schwabl, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
Pageof 50

Showing results (221-230 of 491) with videos related to

Sort By:
Pageof 50
United European Gastroenterology Journal|June 19, 2019
Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascitesBenedikt Simbrunner, Annika Röthenbacher, Helmuth Haslacher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 6, 2022
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertensionDavid Bauer, Karin Kozbial, Philipp Schwabl, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|February 28, 2022
Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled ElastographyDavid Jm Bauer, Vladimir Matic, Ruxandra Mare, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2013
Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingThomas Reiberger, Berit Anna Payer, Philipp Schwabl, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Hepatology International|March 7, 2023
Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory responseBenedikt Simbrunner, Esther Caparrós, Teresa Neuwirth, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Journal of Hepatology|March 1, 2023
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysisAntonio Guerrero, Laura Del Campo, Fabio Piscaglia, et al.
Pageof 50